Asia-ARVO Travel Awards and Symposium

Asia-ARVO 旅游奖暨研讨会

• 批准号: 8007118
• 负责人: SALLY S ATHERTON
• 金额: $ 3万
• 依托单位: ASSOCIATION FOR RES IN VISION & OPHTHAL
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-01 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8007118
• 关键词: Affect; Amblyopia; Area; Asia; Asians; Award; Basic Science; Blindness; Cataract; Clinical; Clinical Research; Collaborations; Corneal Diseases; Country; Disease; Doctor of Philosophy; Educational workshop; Eye; Eye Infections; Eye diseases; Funding; Future; Genetic; Genomics; Glaucoma; Goals; Health; Immune response; Immunology; Inflammation; Institution; International; Myopia; Nanotechnology; National Eye Institute; Ophthalmology; Paper; Proteomics; Refractive Errors; Rehabilitation therapy; Research; Research Institute; Research Personnel; Retinal Diseases; Scientist; Singapore; Strabismus; Therapeutic; Therapeutic Intervention; Translational Research; Travel; United States; United States National Institutes of Health; Vision; Vision research; Visual impairment; combat; global health; health disparity; high throughput technology; innovation; interest; lens; meetings; optic nerve disorder; posters; programs; public health relevance; symposium; visual process; visual processing

DESCRIPTION (provided by applicant): Asia-ARVO is an official meeting of the Association for Research in Vision and Ophthalmology (ARVO) and is held every two years in different Asian countries. The 2011 Asia-ARVO meeting will be in Singapore (January 20-22, 2011). The content of the meeting includes poster sessions, paper sessions, workshops, and symposia that cover program areas supported by the National Eye Institute (NEI) of the United States National Institutes of Health (NIH), including: retinal diseases; corneal diseases; lens and cataract; glaucoma and optic neuropathies; strabismus, amblyopia, and visual processing; low vision and blindness rehabilitation; ocular genetics; ocular infection, inflammation, and immunology; myopia and refractive error; and collaborative clinical research. The program will also focus on areas of interest highlighted by NIH Director, Francis Collins, MD, PhD, when he discussed the future of NIH including translational research, global health, high throughput technologies (genomics, proteomics, and nanotechnology), and health disparities. This application is a request for funds to enhance the exchange of scientific information between the United States and Asia by supporting travel awards for vision researchers from United States institutions (who must be permanent United States residents or citizens) to attend the Asia-ARVO meeting and also for funds to support a symposium entitled: Immune Responses in Infectious Ocular Disease. The third Asia-ARVO meeting will be held in Singapore (January 20-22, 2011), and local meeting arrangements will be made by the Singapore Eye Research Institute (SERI). Over 1,200 vision researchers from over 30 countries are expected to attend the meeting. The primary goal of the 2011 Asia-ARVO meeting is to promote information exchange among basic and clinical vision scientists. Scientific sessions will emphasize eye diseases and conditions that affect people in Asia. The purpose of the meeting is to share research ideas, establish international collaborations, allow international networking, and facilitate advances in understanding mechanisms of as well as therapeutic interventions for eye diseases. PUBLIC HEALTH RELEVANCE: The Asia-ARVO meeting is held every other year, alternating between Singapore and another Asian country. The objectives of the meeting are presentation of: 1) cutting edge vision research in clinical and basic sciences, 2) innovative scientific and poster sessions, and 3) recent therapeutic advances to combat global blindness. The Asia- ARVO conference is the only regional eye and vision research meeting in an area of the world that although it has an expanding vision research capacity still has dramatic disparities in vision health.

描述（由申请人提供）：Asia-ARVO是视觉与眼科研究协会（ARVO）的官方会议，每两年在不同的亚洲国家举行一次。2011年亚洲ARVO会议将在新加坡举行（2011年1月20日至22日）。会议内容包括海报会议、论文会议、讲习班和专题讨论会，涵盖美国国立卫生研究院（NIH）国家眼科研究所（NEI）支持的项目领域，包括：视网膜疾病;角膜疾病;透镜和白内障;青光眼和视神经病变;斜视、弱视和视觉处理;低视力和失明康复;眼部遗传学;眼部感染、炎症和免疫学;近视和屈光不正;以及合作临床研究。该计划还将重点关注NIH主任弗朗西斯柯林斯，医学博士，博士，当他讨论了NIH的未来，包括转化研究，全球健康，高通量技术（基因组学，蛋白质组学和纳米技术），以及健康差距。这项申请要求提供资金，以加强美国和亚洲之间的科学信息交流，支持美国机构的视力研究人员（必须是美国永久居民或公民）参加亚洲-ARVO会议的旅行奖励，并要求提供资金支持题为：传染性眼病的免疫反应的研讨会。第三届亚洲-ARVO会议将在新加坡举行（2011年1月20-22日），当地会议安排将由新加坡眼科研究所（SERI）负责。预计来自30多个国家的1,200多名视觉研究人员将出席会议。2011年亚洲ARVO会议的主要目标是促进基础和临床视觉科学家之间的信息交流。科学会议将强调影响亚洲人民的眼疾和眼疾。会议的目的是分享研究思路，建立国际合作，允许国际网络，并促进对眼科疾病机制和治疗干预的理解。 公共卫生相关性：亚洲-ARVO会议每两年举行一次，在新加坡和另一个亚洲国家之间交替举行。会议的目的是介绍：1）临床和基础科学的前沿视觉研究，2）创新的科学和海报会议，3）最近的治疗进展，以打击全球失明。亚洲- ARVO会议是世界上唯一一个地区性的眼睛和视力研究会议，尽管它具有不断扩大的视力研究能力，但在视力健康方面仍然存在巨大的差距。